Cargando…
Rethinking Biosynthesis of Aclacinomycin A
Aclacinomycin A (ACM-A) is an anthracycline antitumor agent widely used in clinical practice. The current industrial production of ACM-A relies primarily on chemical synthesis and microbial fermentation. However, chemical synthesis involves multiple reactions which give rise to high production costs...
Autores principales: | Xu, Ziling, Tian, Pingfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054333/ https://www.ncbi.nlm.nih.gov/pubmed/36985733 http://dx.doi.org/10.3390/molecules28062761 |
Ejemplares similares
-
Role of the aclacinomycin A--doxorubicin association in reversal of doxorubicin resistance in K562 tumour cells.
por: Millot, J. M., et al.
Publicado: (1989) -
RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancer
por: Feng, Chan, et al.
Publicado: (2015) -
Rethinking the Origin of Auxin Biosynthesis in Plants
por: Ke, Meng, et al.
Publicado: (2015) -
Enhancing effect of β-elemene emulsion on chemotherapy with harringtonine, aclacinomycin, and Ara-c in treatment of refractory/relapsed acute myeloid leukemia
por: Zheng, Cuiping, et al.
Publicado: (2014) -
Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation
por: Lee, Yueh-Lun, et al.
Publicado: (2013)